Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

AIDS/HIV Therapy

Systematic HAART for HIV patients with >500 T cell counts not supported by data

"To assess the clinical, immunological and virological evolution in HIV-1 infected patients with CD4 T-cell count above 500/mm³, a historical cohort of 202 untreated and 96 patients treated with HAART was longitudinally studied (median follow up 36 months)," wrote investigators in France.

"Fourteen untreated and 2 treated patients experienced clinical progression (p=.09). The difference between baseline CD4 T-cell count and after 3 years was -240/mm³ in the untreated group vs. +19/mm³ in the HAART...

• View Other Issues of Blood Weekly
  
• View Other NewsRx Publications